These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3704209)

  • 1. A critical appraisal of the duration of chronic animal toxicity studies.
    Lumley CE; Walker SR
    Regul Toxicol Pharmacol; 1986 Mar; 6(1):66-72. PubMed ID: 3704209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of chronic animal toxicology studies of pharmaceutical compounds: A retrospective analysis.
    Lumley CE; Walker SR
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 1):1007-24. PubMed ID: 4092866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The questionable value of long-term animal toxicity studies: a regulatory dilemma.
    Lumley CE; Walker SR
    Arch Toxicol Suppl; 1986; 9():237-9. PubMed ID: 3468901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An international appraisal of the minimum duration of chronic animal toxicity studies.
    Lumley CE; Parkinson C; Walker SR
    Hum Exp Toxicol; 1992 May; 11(3):155-62. PubMed ID: 1352109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative retrospective analysis of data from short- and long-term animal toxicity studies on 40 pharmaceutical compounds.
    Walker SR; Schuetz E; Schuppan D; Gelzer J
    Arch Toxicol Suppl; 1984; 7():485-7. PubMed ID: 6596020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal studies in safety pharmacology and toxicology: A survey conducted in the top 15 pharmaceutical companies.
    Benjamin A; Gallacher DJ; Greiter-Wilke A; Guillon JM; Kasai C; Ledieu D; Levesque P; Prelle K; Ratcliffe S; Sannajust F; Valentin JP
    J Pharmacol Toxicol Methods; 2015; 75():101-10. PubMed ID: 25637943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A global pharmaceutical company initiative: an evidence-based approach to define the upper limit of body weight loss in short term toxicity studies.
    Chapman K; Sewell F; Allais L; Delongeas JL; Donald E; Festag M; Kervyn S; Ockert D; Nogues V; Palmer H; Popovic M; Roosen W; Schoenmakers A; Somers K; Stark C; Stei P; Robinson S
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):27-38. PubMed ID: 23602904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The duration of non-rodent toxicity studies for pharmaceuticals. International Conference on Harmonication (ICH).
    DeGeorge JJ; Meyers LL; Takahashi M; Contrera JF
    Toxicol Sci; 1999 Jun; 49(2):143-55. PubMed ID: 10416259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey.
    Hammond TG; Carlsson L; Davis AS; Lynch WG; MacKenzie I; Redfern WS; Sullivan AT; Camm AJ
    Cardiovasc Res; 2001 Mar; 49(4):741-50. PubMed ID: 11230973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A toxicology databank based on animal safety evaluation studies of pharmaceutical compounds.
    Lumley CE; Walker SR
    Hum Toxicol; 1985 Jul; 4(4):447-59. PubMed ID: 4018825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of information generated by long-term toxicity studies in the dog for the nonclinical safety assessment of pharmaceutical compounds.
    Parkinson C; Lumley CE; Walker SR
    Fundam Appl Toxicol; 1995 Apr; 25(1):115-23. PubMed ID: 7601320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of carcinogenicity studies of medicinal products for human use authorised via the European centralised procedure (1995-2009).
    Friedrich A; Olejniczak K
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):225-48. PubMed ID: 21513764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the dog in toxicity tests on pharmaceutical compounds.
    Parkinson C; Grasso P
    Hum Exp Toxicol; 1993 Mar; 12(2):99-109. PubMed ID: 8096722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory acceptance of animal models of disease to support clinical trials of medicines and advanced therapy medicinal products.
    Cavagnaro J; Silva Lima B
    Eur J Pharmacol; 2015 Jul; 759():51-62. PubMed ID: 25814257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed Matrix Method Provides A Reliable Metabolite Exposure Comparison for Assessment of Metabolites in Safety Testing (MIST).
    Takahashi RH; Khojasteh C; Wright M; Hop CECA; Ma S
    Drug Metab Lett; 2017 Nov; 11(1):21-28. PubMed ID: 28699487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do the top 12 pharmaceutical companies operate safety pharmacology?
    Ewart L; Gallacher DJ; Gintant G; Guillon JM; Leishman D; Levesque P; McMahon N; Mylecraine L; Sanders M; Suter W; Wallis R; Valentin JP
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):66-70. PubMed ID: 22510338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.